JL, K., YJ, X., QT, Z., B, Z., X, X., & B, Y. (2026). Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target. Oncology research, 34(7), 23. https://doi.org/10.32604/or.2026.079221
Chicago Style (17th ed.) CitationJL, Kang, Xu YJ, Zhao QT, Zhang B, Xu X, and Yang B. "Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target." Oncology Research 34, no. 7 (2026): 23. https://doi.org/10.32604/or.2026.079221.
MLA (9th ed.) CitationJL, Kang, et al. "Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target." Oncology Research, vol. 34, no. 7, 2026, p. 23, https://doi.org/10.32604/or.2026.079221.